On March 4, 2025, PurposeMed, a Calgary-based telehealth company, announced the successful completion of its growth financing round led by True North Fund, with significant participation from BDC and Panache Ventures.

PurposeMed specializes in providing accessible and specialized healthcare services to underserved populations across Canada and the United States. 

True North Fund is a Canadian growth-stage venture capital firm dedicated to supporting top-performing Canadian tech founders.

Osler, Hoskin & Harcourt LLP advised PurposeMed with a team consisting of Mark Longo, Michael Grantmyre, Ian Nelson, JD D’Souza (Emerging and High Growth Companies) and Gaby Fekete (articling student).

Dentons advised BDC with a team led by Manveer Bisla (Vancouver, Corporate, Securities and Corporate Finance, VTEGC), David Little (Ottawa, VTEGC), Andrea Johnson (Ottawa, Corporate, M&A, Private Equity, VTEGC).